Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
CStone Pharmaceuticals
company
About
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $260M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Dec 23, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative tumor immunotherapy and precision treatment drugs to meet the intensive medical needs of cancer patients in China and around the world.CStone Pharmaceuticals has assembled a world-class management team with extensive experience in new drug development, clinical research, and commercialization. The company has built a rich product pipeline composed of 15 tumor candidate drugs with the combination of tumor immunotherapy as the core.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$260M
CStone Pharmaceuticals has raised a total of
$260M
in funding over 2 rounds. Their latest funding was raised on
May 9, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 9, 2018 | Series B | $260M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
CStone Pharmaceuticals is funded by 2 investors.
ARCH Venture Partners
and King Star Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
